PS
Pradeep Saxena
About Pradeep Saxena
Data last updated:
Pradeep Saxena is a Director at Rexcin Pharmaceuticals Private Limited (since 2013), Director at Best Laboratories Private Limited (since 2018) and Director at Rexcin Healthcare Private Limited (since 2018), and holds 1 more current directorship. The companies operate in Pharma and Chemicals. The 4 current companies with reported revenue have a combined latest revenue of ₹10.53 Cr; the largest is Rexcin Pharmaceuticals Private Limited at ₹8.57 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 31 Jul 2013 | 2003 | ₹8.57 Cr (FY 2025) | Active | |
| Director | 29 Mar 2018 | 2003 | ₹1.91 Cr (FY 2025) | Active | |
| Director | 29 Mar 2018 | 2003 | ₹4.3 Lakh (FY 2025) | Active | |
| Director | 29 Mar 2018 | 2003 | ₹53,360 (FY 2025) | Active |
Board colleagues of Pradeep Saxena
| Name | DIN | Company | Designation |
|---|---|---|---|
| Satinder Pal Singh | 02676056 | Rexcin Pharmaceuticals Private Limited , Best Laboratories Private Limited and 2 more | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Pradeep Saxena
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pradeep Saxena
Pradeep Saxena currently holds 4 directorships: Rexcin Pharmaceuticals Private Limited (Director, since 31 Jul 2013, revenue ₹8.57 Cr (FY 2025)); Best Laboratories Private Limited (Director, since 29 Mar 2018, revenue ₹1.91 Cr (FY 2025)); Rexcin Healthcare Private Limited (Director, since 29 Mar 2018, revenue ₹4.3 Lakh (FY 2025)); Rexcin Drugs Private Limited (Director, since 29 Mar 2018, revenue ₹53,360 (FY 2025)).
Pradeep Saxena was first appointed on 31 Jul 2013 as Director at Rexcin Pharmaceuticals Private Limited. The most recent appointment on record is 29 Mar 2018 at Rexcin Drugs Private Limited.
The 4 current companies of Pradeep Saxena that report revenue have a combined latest revenue of ₹10.53 Cr: Rexcin Pharmaceuticals Private Limited ₹8.57 Cr (FY 2025); Best Laboratories Private Limited ₹1.91 Cr (FY 2025); Rexcin Healthcare Private Limited ₹4.3 Lakh (FY 2025); Rexcin Drugs Private Limited ₹53,360 (FY 2025).
The current boards of Pradeep Saxena's companies include Satinder Pal Singh (Rexcin Pharmaceuticals Private Limited).